Cargando…
Synergistic Effects of the Combinational Use of Escitalopram Oxalate and 5-Fluorouracil on the Inhibition of Gastric Cancer SNU-1 Cells
Owing to its high recurrence rate, gastric cancer (GC) is the leading cause of tumor-related deaths worldwide. Besides surgical treatment, chemotherapy is the most commonly used treatment against GC. However, the adverse events associated with chemotherapy use limit its effectiveness in GC treatment...
Autores principales: | Chen, Vincent Chin-Hung, Huang, Jing-Yu, Tzang, Bor-Show, Hsu, Tsai-Ching, McIntyre, Roger S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781210/ https://www.ncbi.nlm.nih.gov/pubmed/36555820 http://dx.doi.org/10.3390/ijms232416179 |
Ejemplares similares
-
Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2023) -
Escitalopram oxalate induces apoptosis in U‐87MG cells and autophagy in GBM8401 cells
por: Chen, Vincent Chin‐Hung, et al.
Publicado: (2017) -
Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy
por: Chen, Li-Jeng, et al.
Publicado: (2022) -
Association of Risperidone With Gastric Cancer: Triangulation Method From Cell Study, Animal Study, and Cohort Study
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2022) -
Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018)